David F Novack Dynavax Technologies Corp (DVAX) insider trading activity

David F Novack is President & COO of DYNAVAX TECHNOLOGIES CORP. Currently has a direct ownership of 63,344 shares of DVAX, which is worth approximately $700,584. The most recent transaction as insider was on Dec 24, 2025, when has been sold 48,107 shares (Common Stock) at a price of $15.38 per share, resulting in proceeds of $739,885. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 63.3K

684.15% 3M change

186.75% 12M change

Total Value Held $700,584

David F Novack Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Dec 24 2025	SELL Payment of exercise price or tax liability	$739,885 $15.38 p/Share	48,107 Reduced 43.16%	63,344 Common Stock
Dec 24 2025	SELL Open market or private sale	$464,700 $15.49 p/Share	30,000 Reduced 21.21%	111,451 Common Stock
Dec 24 2025	BUY Exercise of conversion of derivative security	$259,200 $8.64 p/Share	30,000 Added 17.5%	141,451 Common Stock
Dec 23 2025	BUY Exercise of conversion of derivative security	-	41,408 Added 27.09%	111,451 Common Stock
Dec 23 2025	BUY Grant, award, or other acquisition	-	60,625 Added 46.4%	70,043 Common Stock
Mar 24 2025	SELL Open market or private sale	$140,000 $14.0 p/Share	10,000 Reduced 55.32%	8,078 Common Stock
Mar 24 2025	BUY Exercise of conversion of derivative security	$68,000 $6.8 p/Share	10,000 Added 35.62%	18,078 Common Stock

Mar 18 2025	SELL Open market or private sale	$190,391 $13.58 p/Share	14,020 Reduced 63.44%	8,078 Common Stock
Mar 07 2025	SELL Open market or private sale	$471,473 $14.39 p/Share	32,764 Reduced 59.72%	22,098 Common Stock
Feb 18 2025	SELL Payment of exercise price or tax liability	$137,898 $12.93 p/Share	10,665 Reduced 16.28%	54,862 Common Stock
Feb 18 2025	BUY Exercise of conversion of derivative security	-	22,620 Added 25.66%	65,527 Common Stock
Feb 13 2025	SELL Payment of exercise price or tax liability	$158,371 $12.69 p/Share	12,480 Reduced 22.53%	42,907 Common Stock
Feb 13 2025	BUY Exercise of conversion of derivative security	-	26,500 Added 32.86%	54,156 Common Stock
Feb 10 2025	SELL Payment of exercise price or tax liability	$59,637 $13.2 p/Share	4,518 Reduced 14.04%	27,656 Common Stock
Feb 10 2025	BUY Exercise of conversion of derivative security	-	8,833 Added 21.54%	32,174 Common Stock
Feb 15 2024	BUY Grant, award, or other acquisition	$11,406 $9.45 p/Share	1,207 Added 5.18%	22,090 Common Stock
Feb 12 2024	SELL Payment of exercise price or tax liability	$40,395 $12.82 p/Share	3,151 Reduced 13.11%	20,883 Common Stock
Feb 10 2024	BUY Exercise of conversion of derivative security	-	8,833 Added 26.87%	24,034 Common Stock
Feb 05 2024	SELL Payment of exercise price or tax liability	$85,539 $12.79 p/Share	6,688 Reduced 30.55%	15,201 Common Stock
Feb 03 2024	BUY Exercise of conversion of derivative security	-	17,500 Added 44.43%	21,889 Common Stock
Jan 02 2024	SELL Open market or private sale	$130,050 $14.45 p/Share	9,000 Reduced 73.85%	3,187 Common Stock
Jan 02 2024	BUY Exercise of conversion of derivative security	$48,780 $5.42 p/Share	9,000 Added 42.48%	12,187 Common Stock
Dec 01 2023	SELL Open market or private sale	$271,200 $13.56 p/Share	20,000 Reduced 86.26%	3,187 Common Stock
Dec 01 2023	BUY Exercise of conversion of derivative security	$108,400 $5.42 p/Share	20,000 Added 46.31%	23,187 Common Stock
Nov 03 2023	SELL Open market or private sale	$300,000 $15.0 p/Share	20,000 Reduced 86.26%	3,187 Common Stock

DFN

David F Novack

President & COO

Emeryville, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells DVAX shares.

Notify only if

Value

Insider Trading

Get notified when an Dynavax Technologies Corp insider buys or sells DVAX shares.

Notify only if

Operation

Value

Type

News

Receive news related to DYNAVAX TECHNOLOGIES CORP

Track Activities on DVAX

Account